# Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function

> **NCT07682818** · PHASE1 · RECRUITING · sponsor: **Zealand Pharma** · enrollment: 36 (estimated)

## Conditions studied

- Impaired Hepatic Function

## Interventions

- **DRUG:** Petrelintide

## Key facts

- **NCT ID:** NCT07682818
- **Lead sponsor:** Zealand Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-18
- **Primary completion:** 2027-04-12
- **Final completion:** 2027-04-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07682818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07682818, "Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07682818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*